Daily Record, The (Baltimore) - Md.-based Advancis Pharmaceutical Corp. freezes development, looks
Friday, October 31st, 2008 As Advancis Pharmaceutical Corp. faces growing losses and regulatory challenges, the Germantown-based drug firm is cutting costs by controlling staff size, freezing most of its development programs and actively seeking a partner for acquisition.
The company, which has only one commercialized product, the antibiotic Keflex, had a net loss of $41.99 million in 2006, compared with a $32.99 million loss for 2005.
Its revenue fo…
